1. Home
  2. MDAIW vs HTLD Comparison

MDAIW vs HTLD Comparison

Compare MDAIW & HTLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • HTLD
  • Stock Information
  • Founded
  • MDAIW N/A
  • HTLD 1978
  • Country
  • MDAIW United States
  • HTLD United States
  • Employees
  • MDAIW 78
  • HTLD N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • HTLD Trucking Freight/Courier Services
  • Sector
  • MDAIW Health Care
  • HTLD Industrials
  • Exchange
  • MDAIW Nasdaq
  • HTLD Nasdaq
  • Market Cap
  • MDAIW N/A
  • HTLD N/A
  • IPO Year
  • MDAIW N/A
  • HTLD N/A
  • Fundamental
  • Price
  • MDAIW $0.37
  • HTLD $8.95
  • Analyst Decision
  • MDAIW
  • HTLD Sell
  • Analyst Count
  • MDAIW 0
  • HTLD 3
  • Target Price
  • MDAIW N/A
  • HTLD $10.00
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • HTLD 769.2K
  • Earning Date
  • MDAIW 02-27-2025
  • HTLD 07-22-2025
  • Dividend Yield
  • MDAIW N/A
  • HTLD 0.89%
  • EPS Growth
  • MDAIW N/A
  • HTLD N/A
  • EPS
  • MDAIW N/A
  • HTLD N/A
  • Revenue
  • MDAIW $27,264,000.00
  • HTLD $996,611,000.00
  • Revenue This Year
  • MDAIW N/A
  • HTLD N/A
  • Revenue Next Year
  • MDAIW N/A
  • HTLD $7.04
  • P/E Ratio
  • MDAIW N/A
  • HTLD N/A
  • Revenue Growth
  • MDAIW 44.52
  • HTLD N/A
  • 52 Week Low
  • MDAIW $0.08
  • HTLD $7.11
  • 52 Week High
  • MDAIW $0.90
  • HTLD $13.67
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • HTLD 56.29
  • Support Level
  • MDAIW N/A
  • HTLD $8.87
  • Resistance Level
  • MDAIW N/A
  • HTLD $9.10
  • Average True Range (ATR)
  • MDAIW 0.00
  • HTLD 0.19
  • MACD
  • MDAIW 0.00
  • HTLD 0.04
  • Stochastic Oscillator
  • MDAIW 0.00
  • HTLD 60.78

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: